SPECTROPHOTOMETRIC DETERMINATION OF ATENOLOL IN DOSAGE FORMS USING 2,3-DICHLORO-1,4-NAPHTOQUINONE

Authors

  • А. О. Donchenko Zaporizhzhia State Medical University
  • S. O. Vasyuk Zaporizhzhia State Medical University

DOI:

https://doi.org/10.11603/2312-0967.2017.4.8397

Keywords:

atenolol, 2, 3-dichloro-1, 4-napthoquinone, spectrophotometry, assay, validation studies.

Abstract

The aim of the work. Developing and validating the spectrophotometric method for atenolol assay using absorption spectrophotometry.

Materials and Methods. Atenolol working standard, 2,3-dichloro-1,4-naphthoquinone and the sample of finished dosage forms were used.

Results and Discussion. It was experimentally established that atenolol reacts with 2,3-dichloro-1,4-naphthoquinone in DMF medium to formation the colored reaction product with absorption maximum at 493 nm. The proposed method was subjected to validation tests. The method was validated for the parameters like linearity, precision, accuracy, robustness and scope of application. Beer’s law was obeyed over the concentration range of 11.20–19.60 mg/100 ml with correlation coeffіcient 0.9990. The linearity ranges were calculated with the help of regression analysis by means of least squares.

Conclusion. The spectrophotometric method of atenolol assay was developed and validated. This procedure is successfully applied for dosage forms analysis. Investigation results show that the procedure is precise, simple and relevant to be applied at the quality control laboratories for dosage forms.

Author Biographies

А. О. Donchenko, Zaporizhzhia State Medical University

PG student of Analytical Chemistry Department, Zaporizhzhia State Medical University, Ukraine.

S. O. Vasyuk, Zaporizhzhia State Medical University

PharmDr., Professor, HeadofAnalyticalChemistryDepartment, Zaporizhzhia State Medical University, Ukraine.

References

Kovalenko VM, Dorohoy AP. [Cardiovascular disease: medical and social significance and the strategy of cardiology development in Ukraine]. Ukrainskyi kardiolohichnyi zhurnal. 2016:5-14. Ukrainian.

Kuyper L, Khan N. Atenolol vs Nonatenolol β-Blockers for the Treatment of Hypertension: A Meta-analysis. Can J Cardiol [Internet]. 2014;30(5): 47-53. Available from: http://dx.doi.org/10.1016/j.cjca.2014.01.006.

Mashkovskiy MD. Medicine remedies. [Лекарственные средства]. Moscow: Novaya Volna, 2012. Russian.

State Pharmacopoeia of Ukraine. 2nd ed. Kharkiv: Naukovo-ekspertniy farmakopeyniy tsentr; 2015.

British Pharmacopeia. London: The Stationary Office; 2009.

United States Pharmacopeia. 36th ed. Rockville: USP Convention Inc, 2013.

Zhuk Y, Vasyuk S. Quantitative determination of Atenolol in tablets. IJAPBC. 2015;5(3): 350-4.

Anderson J, Gerlin M, Sversut R, Oliveira L, Singh A, Amaral M et al. Development and validation of an isocratic HPLC method for simultaneous determination of quaternary mixtures of antihypertensive drugs in pharmaceutical formulations. Acta Chromatogr [Internet]. 2017;29(1): 95-110. Available from: https://doi.org/10.1556/1326.2017.29.1.9

Dey S, Sarkar S, Malakar J, Mazumder B. Spectrophotometric method for simultaneous determination of atenolol and atorvastatin in tablet dosage forms. Int J Pharm Biomed Res. 2012;3(1): 40-3.

Patil P, Raj H, Sonara G. Q-Absorbance Ratio Spectrophotometric method for simultaneous determination of Atenolol and Ivabradine HCl in synthetic mixture. Pharm and Biol Eval. 2016;3(2): 224-30.

Grisodub AI. Standardized procedures for the validation of drug quality control methods. Kharkov: Gosudarstvennoye predpriyatiye «Ukrainskiy nauchnyy farmakopeynyy tsentr kachestva lekarstvennykh sredstv; 2016. Russian.

Published

2017-12-29

How to Cite

Donchenko А. О., & Vasyuk, S. O. (2017). SPECTROPHOTOMETRIC DETERMINATION OF ATENOLOL IN DOSAGE FORMS USING 2,3-DICHLORO-1,4-NAPHTOQUINONE. Pharmaceutical Review Farmacevtičnij časopis, (4), 63–68. https://doi.org/10.11603/2312-0967.2017.4.8397

Issue

Section

Analysis of drugs